1139
|
Prevnar 20
|
Pneumococcal
|
Streptococcus pneumoniae
|
Conjugate
|
Pfizer
|
Approved
|
Intramuscular
|
NA
|
NA
|
1140
|
Prevnar 13
|
Pneumococcal
|
Streptococcus pneumoniae
|
Inactivated
|
Pfizer
|
Approved
|
Intramuscular
|
NA
|
NA
|
1141
|
Prevnar
|
Pneumococcal
|
Streptococcus pneumoniae
|
Inactivated
|
Wyeth Pharmaceuticals Inc.
|
Approved
|
Intramuscular
|
NA
|
NA
|
1142
|
Pneumovax 23
|
Pneumococcal
|
Streptococcus pneumoniae
|
Polysaccharide
|
Merck & Co.
|
Approved
|
Intramuscular
|
NA
|
NA
|
1143
|
VAXNEUVANCE
|
Pneumococcal
|
Streptococcus pneumoniae
|
Conjugate
|
Merck Sharp & Dohme Corp.
|
Approved
|
Intramuscular
|
NA
|
NA
|
1144
|
Synflorix
|
Pneumococcal
|
Streptococcus pneumoniae
|
Conjugate
|
GlaxoSmithKline Biologicals
|
Approved
|
Intramuscular
|
NA
|
NA
|
1145
|
Pneumosil
|
Pneumococcal
|
Streptococcus pneumoniae
|
Conjugate
|
By collaboration between Serum Institute of India Pvt Ltd and PATH.
|
Approved
|
Intramuscular
|
NA
|
NA
|
1342
|
ProDiax-23
|
Pneumococcal
|
Streptococcus pneumoniae
|
Polysaccharide
|
Korea University Guro Hospital
|
Clinical - Phase 4
|
Intramuscular
|
NA
|
NCT04875858
|
1343
|
V114
|
Pneumococcal
|
Streptococcus pneumoniae
|
Conjugate
|
Merck Sharp & Dohme Corp.
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT03547167
|
1344
|
NBP606
|
Pneumococcal
|
Streptococcus pneumoniae
|
Conjugate
|
SK Chemicals Co., Ltd.
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT02201030
|
1345
|
PCV13i
|
Pneumococcal
|
Streptococcus pneumoniae
|
Conjugate
|
CanSino Biologics Inc.
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT04841369
|
1346
|
GSK513026
|
Pneumococcal
|
Streptococcus pneumoniae
|
NA
|
GlaxoSmithKline
|
Clinical - Phase 2
|
Intramuscular
|
NA
|
NCT00307528
|
1347
|
LBVE
|
Pneumococcal
|
Streptococcus pneumoniae
|
Conjugate
|
LG Chem
|
Clinical - Phase 2
|
Intramuscular
|
NA
|
NCT03467984
|
1348
|
PNCRM9
|
Pneumococcal
|
Streptococcus pneumoniae
|
Conjugate
|
National Institute of Allergy and Infectious Diseases (NIAID)
|
Clinical - Phase 2
|
Intramuscular
|
NA
|
NCT00133549
|
1349
|
GEN-004
|
Pneumococcal
|
Streptococcus pneumoniae
|
Subunit
|
Genocea Biosciences, Inc.
|
Clinical - Phase 2
|
Intramuscular
|
NA
|
NCT02116998
|